Arie Carneiro

Arie Carneiro

Auto-generated profile, based on publicly available information

Arie Carneiro

Hospital Israelita Albert Einstein, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Urology
Verified
Journal Article
Closed access
RTRafael R. Tourinho-Barbosa
Rafael R. Tourinho-Barbosa
RSRafael Sanchez-Salas
Rafael Sanchez-Salas
OCOliver Rojas Claros
Oliver Rojas Claros
SCSylvain Collura-Merlier
Sylvain Collura-Merlier
ABArnas Bakavicius
Arnas Bakavicius
XCXavier Cathelineau
Xavier Cathelineau
Purpose:We reported oncologic outcomes of patients treated with focal therapy (FT) for prostate cancer (PCa).Materials and Methods:We retrospectively analyzed a single-institution cohort of men wit...

1 September 2020 in European Urology Focus
Verified
Journal Article
Closed access
FHFlavio Lobo Heldwein
Flavio Lobo Heldwein
SLStacy Loeb
Stacy Loeb
MWMarcelo Langer Wroclawski
Marcelo Langer Wroclawski
ASAshwin Narasimha Sridhar
Ashwin Narasimha Sridhar
ACArie Carneiro
Arie Carneiro
JTJeremy Yuen-Chun Teoh
Jeremy Yuen-Chun Teoh

1 January 2020 in International braz j urol
Verified
Journal Article
Open access
PDF file
ACArie Carneiro
Arie Carneiro
MWMarcelo Langer Wroclawski
Marcelo Langer Wroclawski
BNBruno Nahar
Bruno Nahar
ASAndrey Soares
Andrey Soares
ACAna Paula Cardoso
Ana Paula Cardoso
FCFabricio Torres Carvalho
Fabricio Torres Carvalho
The format of the text will be given through questions and answers.

12 November 2014 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
ACArie Carneiro
Arie Carneiro
ASAndre Deeke Sasse
Andre Deeke Sasse
AWAndrew Aurel Wagner
Andrew Aurel Wagner
GPGuilherme Peixoto
Guilherme Peixoto
AKAndré Kataguiri
André Kataguiri
MTMarcos Tobias-Machado
Marcos Tobias-Machado

1 November 2017 in Journal of Urology
Verified
Journal Article
Closed access
INIgor Nunes-Silva
Igor Nunes-Silva
EBEric Barret
Eric Barret
VSVictor Srougi
Victor Srougi
MBMohammed Baghdadi
Mohammed Baghdadi
PCPaolo Capogrosso
Paolo Capogrosso
XCXavier Cathelineau
Xavier Cathelineau
We assessed the impact of focal therapy on perioperative, oncologic and functional outcomes in men who underwent salvage robotic assisted radical prostatectomy compared to primary robotic assisted radical prostatectomy. Focal therapy was performed in patients presenting with Gleason score 3 + 3 or 3 + 4, clinical stage cT2a or less, serum prostate specific antigen 15 ng/ml or less, unilateral positive biopsy, maximum length of any positive core less than 10 mm and life expectancy greater than 10 years. Focal therapy was defined as target ablation of the index lesion plus a 1 cm safety margin in the normal ipsilateral prostatic parenchyma. The salvage group included 22 men who underwent salvage prostatectomy after focal therapy failure. The primary group was defined using matched pair 1:2 selection of 44 of 2,750 patients treated with primary prostatectomy. The primary and secondary end points were the between group differences in functional and oncologic outcomes, respectively. Complication rates were comparable (p >0.05). Pad-free probability was comparable between the groups at 1 and 2 years (p = 0.8). Recovery of erectile function was significantly lower after salvage robotic assisted radical prostatectomy (p = 0.008), which also showed a significantly lower probability of cumulative biochemical recurrence-free survival compared to primary robotic assisted radical prostatectomy (56.3% vs 92.4% at 2 years, p = 0.001). Salvage prostatectomy demonstrated a significantly increased risk of biochemical recurrence (HR 4.8, 95% CI 1.67-13.76, p = 0.004). Study limitations included the retrospective nature, the lack of randomization and the short followup. Salvage robotic assisted radical prostatectomy after focal therapy failure is feasible with acceptable complication rates. However, patients assigned to primary focal therapy should be advised about a poorer prognosis in terms of oncologic control and lower erectile recovery rates in case of a future salvage surgery.

1 May 2020 in Journal of Urology
Verified
Journal Article
Closed access
OCOliver Rojas Claros
Oliver Rojas Claros
RTRafael Rocha Tourinho-Barbosa
Rafael Rocha Tourinho-Barbosa
AFAude Fregeville
Aude Fregeville
AGAnna Colomer Gallardo
Anna Colomer Gallardo
FMFabio Muttin
Fabio Muttin
XCXavier Cathelineau
Xavier Cathelineau
Purpose:We aimed to compare cancer detection rates (CDR) in patients who underwent MRI cognitive guided micro-ultrasound biopsy (MB) versus Robotic ultrasound-magnetic resonance imaging fusion biop...